The worldwide use of fluoroquinolones in community and hospital settings, due to their high efficacy and tolerability, to the wide antibacterial spectrum and to the availability of an oral formulation, has created a relevant selective pressure for the emergence of resistant bacterial strains towards this antimicrobial class. Nevertheless, twenty years after development of the first fluoroquinolones (e.g. norfloxacin and ciprofloxacin) and ten years after levofloxacin introduction, the antibacterial activity of these drugs remains overall high.
|Number of pages||8|
|Journal||Infezioni in Medicina|
|Issue number||SUPPL. 5|
|Publication status||Published - 2009|
ASJC Scopus subject areas
- Infectious Diseases
- Microbiology (medical)